These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23996689)

  • 41. Identification of cooperative genes for E2A-PBX1 to develop acute lymphoblastic leukemia.
    Sera Y; Yamasaki N; Oda H; Nagamachi A; Wolff L; Inukai T; Inaba T; Honda H
    Cancer Sci; 2016 Jul; 107(7):890-8. PubMed ID: 27088431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein.
    Diakos C; Xiao Y; Zheng S; Kager L; Dworzak M; Wiemels JL
    PLoS One; 2014; 9(2):e87602. PubMed ID: 24503810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specific immunologic recognition of the tumor-specific E2A-PBX1 fusion-point antigen in t(1;19)-positive pre-B cells.
    Berendes P; Hoogeveen A; van Dijk M; van Denderen J; van Ewijk W
    Leukemia; 1995 Aug; 9(8):1321-7. PubMed ID: 7643619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Correlation of E2a-pbx1 expression level with clinical characteristics and early response to treatment in children with acute lymphoblastic leukemia].
    Gao C; Li ZG; Zhao W; Wu MY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):569-73. PubMed ID: 18549631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b.
    Kroon E; Krosl J; Thorsteinsdottir U; Baban S; Buchberg AM; Sauvageau G
    EMBO J; 1998 Jul; 17(13):3714-25. PubMed ID: 9649441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inability of HOXB4 to enhance self-renewal of malignant B cells: favorable profile for the expansion of autologous hematopoietic stem cells.
    Fournier M; Savoie-Rondeau I; Larochelle F; Hassawi M; Shestakova EA; Roy DC; Bijl JJ
    Exp Hematol; 2014 Jul; 42(7):526-35.e4. PubMed ID: 24503485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New E2A/PBX1 fusion transcript in a patient with t(1;19)(q23;p13) acute lymphoblastic leukemia.
    Numata S; Kato K; Horibe K
    Leukemia; 1993 Sep; 7(9):1441-4. PubMed ID: 8103813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1.
    McWhirter JR; Goulding M; Weiner JA; Chun J; Murre C
    Development; 1997 Sep; 124(17):3221-32. PubMed ID: 9310317
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.
    Staffas A; Arabanian LS; Wei SY; Jansson A; Ståhlman S; Johansson P; Fogelstrand L; Cammenga J; Kuchenbauer F; Palmqvist L
    Oncogene; 2017 Mar; 36(11):1516-1524. PubMed ID: 27617578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oligomeric self-association contributes to E2A-PBX1-mediated oncogenesis.
    Lin CH; Wang Z; Duque-Afonso J; Wong SH; Demeter J; Loktev AV; Somervaille TCP; Jackson PK; Cleary ML
    Sci Rep; 2019 Mar; 9(1):4915. PubMed ID: 30894657
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia.
    Palmqvist L; Argiropoulos B; Pineault N; Abramovich C; Sly LM; Krystal G; Wan A; Humphries RK
    Blood; 2006 Aug; 108(3):1030-6. PubMed ID: 16861351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of E2A-PBX1 in leukemogenesis.
    Aspland SE; Bendall HH; Murre C
    Oncogene; 2001 Sep; 20(40):5708-17. PubMed ID: 11607820
    [No Abstract]   [Full Text] [Related]  

  • 53. Expression of identical E2A/PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia.
    Izraeli S; Henn T; Strobl H; Ludwig WD; Kovar H; Haas OA; Harbott J; Bartram CR; Gadner H; Lion T
    Leukemia; 1993 Dec; 7(12):2054-6. PubMed ID: 8255105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Spt-Ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1.
    Scheele JS; Kolanczyk M; Gantert M; Zemojtel T; Dorn A; Sykes DB; Möbest DC; Kamps MP; Räpple D
    Leuk Lymphoma; 2009 May; 50(5):816-28. PubMed ID: 19399691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA-binding by oncoprotein E2a-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation.
    Kamps MP; Wright DD; Lu Q
    Oncogene; 1996 Jan; 12(1):19-30. PubMed ID: 8552391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein kinase A-dependent transactivation by the E2A-Pbx1 fusion protein.
    Ogo A; Waterman MR; Kamps MP; Kagawa N
    J Biol Chem; 1995 Oct; 270(43):25340-3. PubMed ID: 7592695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells.
    Takeda A; Goolsby C; Yaseen NR
    Cancer Res; 2006 Jul; 66(13):6628-37. PubMed ID: 16818636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distinct in vivo engraftment and growth patterns of t(1;19)+/E2A-PBX1+ and t(9;22)+/BCR-ABL+ human leukemia cells in SCID mice.
    Waurzyniak BJ; Heerema N; Sensel MG; Gaynon PS; Kraft P; Sather HN; Chelstrom L; Reaman GH; Uckun FM
    Leuk Lymphoma; 1998 Dec; 32(1-2):77-87. PubMed ID: 10037003
    [TBL] [Abstract][Full Text] [Related]  

  • 60. E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.
    Pi WC; Wang J; Shimada M; Lin JW; Geng H; Lee YL; Lu R; Li D; Wang GG; Roeder RG; Chen WY
    Blood; 2020 Jul; 136(1):11-23. PubMed ID: 32276273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.